25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Botanix Pharmaceuticals Ltd
Buy, Hold or Sell?

Let's analyze Botanix Pharmaceuticals Ltd together

I guess you are interested in Botanix Pharmaceuticals Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Botanix Pharmaceuticals Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Botanix Pharmaceuticals Ltd

I send you an email if I find something interesting about Botanix Pharmaceuticals Ltd.

1. Quick Overview

1.1. Quick analysis of Botanix Pharmaceuticals Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Botanix Pharmaceuticals Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
40.0%

What is your share worth?

Current worth
A$0.06
Expected worth in 1 year
A$0.25
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
A$0.19
Return On Investment
38.0%

For what price can you sell your share?

Current Price per Share
A$0.50
Expected price per share
A$0.41 - A$
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Botanix Pharmaceuticals Ltd (5 min.)




Live pricePrice per Share (EOD)
A$0.50
Intrinsic Value Per Share
A$-0.24 - A$-0.11
Total Value Per Share
A$-0.18 - A$-0.05

2.2. Growth of Botanix Pharmaceuticals Ltd (5 min.)




Is Botanix Pharmaceuticals Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$69m$14.5m$54.5m78.9%

How much money is Botanix Pharmaceuticals Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$8.8m-$5.8m-$2.9m-34.0%
Net Profit Margin-2,304.6%-1,000.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Botanix Pharmaceuticals Ltd (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Botanix Pharmaceuticals Ltd?

Welcome investor! Botanix Pharmaceuticals Ltd's management wants to use your money to grow the business. In return you get a share of Botanix Pharmaceuticals Ltd.

First you should know what it really means to hold a share of Botanix Pharmaceuticals Ltd. And how you can make/lose money.

Speculation

The Price per Share of Botanix Pharmaceuticals Ltd is A$0.495. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Botanix Pharmaceuticals Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Botanix Pharmaceuticals Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.06. Based on the TTM, the Book Value Change Per Share is A$0.05 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Botanix Pharmaceuticals Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-1.0%0.00-1.0%0.00-0.6%0.00-0.8%0.00-0.6%
Usd Book Value Change Per Share0.036.0%0.036.0%0.011.0%0.011.5%0.000.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.1%0.000.8%0.000.4%
Usd Total Gains Per Share0.036.0%0.036.0%0.011.1%0.012.3%0.011.2%
Usd Price Per Share0.22-0.22-0.08-0.08-0.06-
Price to Earnings Ratio-45.41--45.41--25.93--25.46--22.15-
Price-to-Total Gains Ratio7.34-7.34-14.73--2.92-0.02-
Price to Book Ratio5.79-5.79-10.34-7.79-62.57-
Price-to-Total Gains Ratio7.34-7.34-14.73--2.92-0.02-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.314523
Number of shares3179
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.030.01
Usd Total Gains Per Share0.030.01
Gains per Quarter (3179 shares)94.9136.27
Gains per Year (3179 shares)379.65145.06
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
103803704996135
2075975099191280
3011391130148287425
4015191510197383570
5018981890247478715
6022782270296574860
70265826503466701005
80303730303957661150
90341734104448611295
100379637904949571440

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%3.031.02.08.3%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%6.04.00.060.0%15.021.00.041.7%
Dividend per Share0.00.01.00.0%2.00.01.066.7%3.00.02.060.0%4.00.06.040.0%9.00.027.025.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%7.03.00.070.0%17.019.00.047.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Botanix Pharmaceuticals Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0470.0470%0.008+480%0.012+297%0.006+706%
Book Value Per Share--0.0600.0600%0.013+374%0.020+195%0.012+415%
Current Ratio--22.21322.2130%7.416+200%14.043+58%11.791+88%
Debt To Asset Ratio--0.0330.0330%0.076-56%0.129-74%0.190-83%
Debt To Equity Ratio--0.0340.0340%0.082-58%0.193-82%0.883-96%
Dividend Per Share----0%0.001-100%0.006-100%0.003-100%
Enterprise Value--705418386.440705418386.4400%245697292.760+187%263440446.950+168%200930050.123+251%
Eps---0.008-0.0080%-0.005-34%-0.006-19%-0.005-34%
Ev To Ebitda Ratio---50.679-50.6790%-26.982-47%-20.961-59%-21.910-57%
Ev To Sales Ratio--1172.1421172.1420%268.530+337%303.111+287%infnan%
Free Cash Flow Per Share---0.014-0.0140%-0.010-27%-0.009-39%-0.006-58%
Free Cash Flow To Equity Per Share--0.0380.0380%0.002+2277%0.008+364%0.004+791%
Gross Profit Margin--1.0241.0240%1.146-11%1.371-25%1.353-24%
Intrinsic Value_10Y_max---0.112--------
Intrinsic Value_10Y_min---0.236--------
Intrinsic Value_1Y_max---0.007--------
Intrinsic Value_1Y_min---0.014--------
Intrinsic Value_3Y_max---0.024--------
Intrinsic Value_3Y_min---0.051--------
Intrinsic Value_5Y_max---0.046--------
Intrinsic Value_5Y_min---0.097--------
Market Cap903686826.240+30%629842333.440629842333.4400%237331893.760+165%237697019.750+165%185502259.423+240%
Net Profit Margin---23.046-23.0460%-10.005-57%-8.105-65%-17.655-23%
Operating Margin---23.249-23.2490%-10.073-57%-8.753-62%-27.872+20%
Operating Ratio--7.0697.0690%14.985-53%6.507+9%24.544-71%
Pb Ratio8.311+30%5.7935.7930%10.341-44%7.787-26%62.565-91%
Pe Ratio-65.155-43%-45.411-45.4110%-25.927-43%-25.460-44%-22.149-51%
Price Per Share0.495+30%0.3450.3450%0.130+165%0.130+165%0.102+240%
Price To Free Cash Flow Ratio-34.589-43%-24.107-24.1070%-12.408-49%-19.409-19%-672.280+2689%
Price To Total Gains Ratio10.535+30%7.3427.3420%14.727-50%-2.915+140%0.018+41027%
Quick Ratio--21.46921.4690%5.697+277%13.444+60%11.484+87%
Return On Assets---0.123-0.1230%-0.369+199%-0.449+264%-0.818+563%
Return On Equity---0.128-0.1280%-0.399+213%-0.602+372%-3.362+2536%
Total Gains Per Share--0.0470.0470%0.009+432%0.018+162%0.009+409%
Usd Book Value--69088661.63569088661.6350%14583082.556+374%23417316.386+195%13408151.454+415%
Usd Book Value Change Per Share--0.0300.0300%0.005+480%0.008+297%0.004+706%
Usd Book Value Per Share--0.0380.0380%0.008+374%0.013+195%0.007+415%
Usd Dividend Per Share----0%0.000-100%0.004-100%0.002-100%
Usd Enterprise Value--448222842.744448222842.7440%156116059.820+187%167390059.992+168%127670953.848+251%
Usd Eps---0.005-0.0050%-0.003-34%-0.004-19%-0.003-34%
Usd Free Cash Flow---16600935.679-16600935.6790%-12153794.589-27%-10139128.505-39%-6906727.471-58%
Usd Free Cash Flow Per Share---0.009-0.0090%-0.007-27%-0.006-39%-0.004-58%
Usd Free Cash Flow To Equity Per Share--0.0240.0240%0.001+2277%0.005+364%0.003+791%
Usd Market Cap574202609.393+30%400201818.668400201818.6680%150800685.295+165%151032686.349+165%117868135.637+240%
Usd Price Per Share0.315+30%0.2190.2190%0.083+165%0.083+165%0.065+240%
Usd Profit---8812813.099-8812813.0990%-5816435.080-34%-7149411.638-19%-5833364.741-34%
Usd Revenue--382396.428382396.4280%581373.844-34%2380549.229-84%1606677.269-76%
Usd Total Gains Per Share--0.0300.0300%0.006+432%0.011+162%0.006+409%
 EOD+6 -2MRQTTM+0 -0YOY+25 -155Y+25 -1510Y+25 -14

3.3 Fundamental Score

Let's check the fundamental score of Botanix Pharmaceuticals Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-65.155
Price to Book Ratio (EOD)Between0-18.311
Net Profit Margin (MRQ)Greater than0-23.046
Operating Margin (MRQ)Greater than0-23.249
Quick Ratio (MRQ)Greater than121.469
Current Ratio (MRQ)Greater than122.213
Debt to Asset Ratio (MRQ)Less than10.033
Debt to Equity Ratio (MRQ)Less than10.034
Return on Equity (MRQ)Greater than0.15-0.128
Return on Assets (MRQ)Greater than0.05-0.123
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Botanix Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.495
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Botanix Pharmaceuticals Ltd

Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia and the United States. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed Phase 3 clinical programs; BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIa clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that is in Phase II clinical trials for the treatment of papulopustular rosacea; and BTX 1204A for the treatment of atopic dermatitis. Botanix Pharmaceuticals Limited was incorporated in 1984 and is based in West Perth, Australia.

Fundamental data was last updated by Penke on 2025-02-05 12:03:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Botanix Pharmaceuticals Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Botanix Pharmaceuticals Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -2,304.6% means that $-23.05 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is -2,304.6%. The company is making a huge loss. -2
  • The TTM is -2,304.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-2,304.6%TTM-2,304.6%0.0%
TTM-2,304.6%YOY-1,000.5%-1,304.2%
TTM-2,304.6%5Y-810.5%-1,494.1%
5Y-810.5%10Y-1,765.5%+955.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2,304.6%-100.3%-2,204.3%
TTM-2,304.6%-211.5%-2,093.1%
YOY-1,000.5%-213.8%-786.7%
5Y-810.5%-346.2%-464.3%
10Y-1,765.5%-489.2%-1,276.3%
4.3.1.2. Return on Assets

Shows how efficient Botanix Pharmaceuticals Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Botanix Pharmaceuticals Ltd to the Biotechnology industry mean.
  • -12.3% Return on Assets means that Botanix Pharmaceuticals Ltd generated $-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is -12.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -12.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.3%TTM-12.3%0.0%
TTM-12.3%YOY-36.9%+24.5%
TTM-12.3%5Y-44.9%+32.5%
5Y-44.9%10Y-81.8%+36.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.3%-12.0%-0.3%
TTM-12.3%-12.1%-0.2%
YOY-36.9%-11.4%-25.5%
5Y-44.9%-12.8%-32.1%
10Y-81.8%-14.6%-67.2%
4.3.1.3. Return on Equity

Shows how efficient Botanix Pharmaceuticals Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Botanix Pharmaceuticals Ltd to the Biotechnology industry mean.
  • -12.8% Return on Equity means Botanix Pharmaceuticals Ltd generated $-0.13 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is -12.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -12.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.8%TTM-12.8%0.0%
TTM-12.8%YOY-39.9%+27.1%
TTM-12.8%5Y-60.2%+47.4%
5Y-60.2%10Y-336.2%+276.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.8%-15.4%+2.6%
TTM-12.8%-16.2%+3.4%
YOY-39.9%-14.7%-25.2%
5Y-60.2%-18.6%-41.6%
10Y-336.2%-19.5%-316.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Botanix Pharmaceuticals Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Botanix Pharmaceuticals Ltd is operating .

  • Measures how much profit Botanix Pharmaceuticals Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Botanix Pharmaceuticals Ltd to the Biotechnology industry mean.
  • An Operating Margin of -2,324.9% means the company generated $-23.25  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is -2,324.9%. The company is operating very inefficient. -2
  • The TTM is -2,324.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-2,324.9%TTM-2,324.9%0.0%
TTM-2,324.9%YOY-1,007.3%-1,317.7%
TTM-2,324.9%5Y-875.3%-1,449.6%
5Y-875.3%10Y-2,787.2%+1,911.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2,324.9%-201.5%-2,123.4%
TTM-2,324.9%-313.4%-2,011.5%
YOY-1,007.3%-215.2%-792.1%
5Y-875.3%-371.8%-503.5%
10Y-2,787.2%-492.1%-2,295.1%
4.3.2.2. Operating Ratio

Measures how efficient Botanix Pharmaceuticals Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 7.07 means that the operating costs are $7.07 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is 7.069. The company is inefficient in keeping operating costs low. -1
  • The TTM is 7.069. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ7.069TTM7.0690.000
TTM7.069YOY14.985-7.916
TTM7.0695Y6.507+0.562
5Y6.50710Y24.544-18.037
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.0692.139+4.930
TTM7.0693.198+3.871
YOY14.9853.358+11.627
5Y6.5074.842+1.665
10Y24.5446.500+18.044
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Botanix Pharmaceuticals Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Botanix Pharmaceuticals Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 22.21 means the company has $22.21 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is 22.213. The company is very able to pay all its short-term debts. +2
  • The TTM is 22.213. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ22.213TTM22.2130.000
TTM22.213YOY7.416+14.797
TTM22.2135Y14.043+8.170
5Y14.04310Y11.791+2.252
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ22.2133.610+18.603
TTM22.2133.871+18.342
YOY7.4164.609+2.807
5Y14.0435.977+8.066
10Y11.7916.216+5.575
4.4.3.2. Quick Ratio

Measures if Botanix Pharmaceuticals Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Botanix Pharmaceuticals Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 21.47 means the company can pay off $21.47 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is 21.469. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 21.469. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ21.469TTM21.4690.000
TTM21.469YOY5.697+15.772
TTM21.4695Y13.444+8.026
5Y13.44410Y11.484+1.960
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ21.4693.085+18.384
TTM21.4693.360+18.109
YOY5.6974.400+1.297
5Y13.4445.972+7.472
10Y11.4846.483+5.001
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Botanix Pharmaceuticals Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Botanix Pharmaceuticals Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Botanix Pharmaceuticals Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.03 means that Botanix Pharmaceuticals Ltd assets are financed with 3.3% credit (debt) and the remaining percentage (100% - 3.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is 0.033. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.033. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.033TTM0.0330.000
TTM0.033YOY0.076-0.043
TTM0.0335Y0.129-0.096
5Y0.12910Y0.190-0.060
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0330.341-0.308
TTM0.0330.343-0.310
YOY0.0760.315-0.239
5Y0.1290.363-0.234
10Y0.1900.384-0.194
4.5.4.2. Debt to Equity Ratio

Measures if Botanix Pharmaceuticals Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Botanix Pharmaceuticals Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 3.4% means that company has $0.03 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Botanix Pharmaceuticals Ltd:

  • The MRQ is 0.034. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.034. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.034TTM0.0340.000
TTM0.034YOY0.082-0.048
TTM0.0345Y0.193-0.159
5Y0.19310Y0.883-0.690
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0340.386-0.352
TTM0.0340.429-0.395
YOY0.0820.391-0.309
5Y0.1930.450-0.257
10Y0.8830.495+0.388
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Botanix Pharmaceuticals Ltd generates.

  • Above 15 is considered overpriced but always compare Botanix Pharmaceuticals Ltd to the Biotechnology industry mean.
  • A PE ratio of -45.41 means the investor is paying $-45.41 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Botanix Pharmaceuticals Ltd:

  • The EOD is -65.155. Based on the earnings, the company is expensive. -2
  • The MRQ is -45.411. Based on the earnings, the company is expensive. -2
  • The TTM is -45.411. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-65.155MRQ-45.411-19.744
MRQ-45.411TTM-45.4110.000
TTM-45.411YOY-25.927-19.485
TTM-45.4115Y-25.460-19.951
5Y-25.46010Y-22.149-3.311
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-65.155-2.247-62.908
MRQ-45.411-2.706-42.705
TTM-45.411-3.253-42.158
YOY-25.927-3.392-22.535
5Y-25.460-6.132-19.328
10Y-22.149-6.735-15.414
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Botanix Pharmaceuticals Ltd:

  • The EOD is -34.589. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -24.107. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -24.107. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-34.589MRQ-24.107-10.481
MRQ-24.107TTM-24.1070.000
TTM-24.107YOY-12.408-11.699
TTM-24.1075Y-19.409-4.698
5Y-19.40910Y-672.280+652.871
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-34.589-3.026-31.563
MRQ-24.107-3.582-20.525
TTM-24.107-3.816-20.291
YOY-12.408-4.463-7.945
5Y-19.409-8.265-11.144
10Y-672.280-9.266-663.014
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Botanix Pharmaceuticals Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 5.79 means the investor is paying $5.79 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Botanix Pharmaceuticals Ltd:

  • The EOD is 8.311. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.793. Based on the equity, the company is overpriced. -1
  • The TTM is 5.793. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD8.311MRQ5.793+2.519
MRQ5.793TTM5.7930.000
TTM5.793YOY10.341-4.548
TTM5.7935Y7.787-1.994
5Y7.78710Y62.565-54.779
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD8.3111.948+6.363
MRQ5.7932.223+3.570
TTM5.7932.427+3.366
YOY10.3412.469+7.872
5Y7.7873.767+4.020
10Y62.5654.507+58.058
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Botanix Pharmaceuticals Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-06-302021-06-302022-06-302023-06-302024-06-30
Other Stockholders Equity  -20,1513,273-16,87913,171-3,708-12,860-16,56816,5680



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets112,465
Total Liabilities3,732
Total Stockholder Equity108,733
 As reported
Total Liabilities 3,732
Total Stockholder Equity+ 108,733
Total Assets = 112,465

Assets

Total Assets112,465
Total Current Assets82,901
Long-term Assets29,563
Total Current Assets
Cash And Cash Equivalents 79,308
Net Receivables 817
Inventory 1,209
Other Current Assets 1,567
Total Current Assets  (as reported)82,901
Total Current Assets  (calculated)82,901
+/-0
Long-term Assets
Property Plant Equipment 72
Intangible Assets 29,492
Other Assets 0
Long-term Assets  (as reported)29,563
Long-term Assets  (calculated)29,563
+/- 0

Liabilities & Shareholders' Equity

Total Current Liabilities3,732
Long-term Liabilities0
Total Stockholder Equity108,733
Total Current Liabilities
Accounts payable 2,728
Other Current Liabilities 1,004
Total Current Liabilities  (as reported)3,732
Total Current Liabilities  (calculated)3,732
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock188,320
Retained Earnings -90,792
Accumulated Other Comprehensive Income 11,204
Total Stockholder Equity (as reported)108,733
Total Stockholder Equity (calculated)108,733
+/-0
Other
Capital Stock188,320
Cash and Short Term Investments 79,308
Common Stock Shares Outstanding 1,501,564
Liabilities and Stockholders Equity 112,465
Net Debt -79,308
Net Invested Capital 108,733
Net Working Capital 79,169
Property Plant and Equipment Gross 72



5.3. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-301998-06-301997-06-301996-06-301995-06-301994-06-301993-06-301992-06-301991-06-301990-06-301989-06-30
> Total Assets 
24,064
25,584
27,413
25,921
38,030
48,565
68,158
57,046
50,262
30,362
16,149
5,268
5,864
4,505
2,938
2,426
3,680
2,508
3,500
2,368
2,017
59
43
18
8
2,553
1,321
3,697
5,907
17,710
5,200
25,311
21,950
14,037
24,836
112,465
112,46524,83614,03721,95025,3115,20017,7105,9073,6971,3212,55381843592,0172,3683,5002,5083,6802,4262,9384,5055,8645,26816,14930,36250,26257,04668,15848,56538,03025,92127,41325,58424,064
   > Total Current Assets 
9,575
10,976
13,616
14,631
21,568
28,161
41,982
26,328
28,854
17,437
8,840
5,268
5,864
3,034
923
2,245
1,707
525
1,522
396
50
52
40
18
8
2,553
1,321
3,697
5,907
17,710
5,188
24,777
21,610
10,501
13,979
82,901
82,90113,97910,50121,61024,7775,18817,7105,9073,6971,3212,5538184052503961,5225251,7072,2459233,0345,8645,2688,84017,43728,85426,32841,98228,16121,56814,63113,61610,9769,575
       Cash And Cash Equivalents 
399
185
718
446
2,076
4,224
5,306
4,551
3,898
4,571
1,605
4,390
5,826
2,964
878
1,307
1,679
512
1,479
373
10
33
7
10
1
2,513
1,309
3,652
5,721
17,263
4,704
24,645
21,555
7,286
10,250
79,308
79,30810,2507,28621,55524,6454,70417,2635,7213,6521,3092,513110733103731,4795121,6791,3078782,9645,8264,3901,6054,5713,8984,5515,3064,2242,076446718185399
       Short-term Investments 
0
0
0
1,395
1,269
1,751
2,044
3,661
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20
0
0
0
0
0
0
000000200000000000000000000003,6612,0441,7511,2691,395000
       Net Receivables 
4,038
4,460
5,868
6,554
8,313
11,094
18,422
11,148
10,576
7,910
4,585
690
38
53
36
939
28
305
44
23
19
13
10
7
7
30
10
38
163
447
483
131
45
141
489
817
81748914145131483447163381030771013192344305289393653386904,5857,91010,57611,14818,42211,0948,3136,5545,8684,4604,038
       Inventory 
5,108
6,285
7,014
6,225
9,904
11,086
16,197
6,949
10,377
3,844
2,644
0
0
0
0
0
0
0
0
0
-21
-6
-23
0
0
-11
0
0
-163
-447
-483
0
3,044
3,044
3,147
1,209
1,2093,1473,0443,0440-483-447-16300-1100-23-6-210000000002,6443,84410,3776,94916,19711,0869,9046,2257,0146,2855,108
       Other Current Assets 
30
46
16
11
6
6
13
19
4,003
1,112
6
188
0
17
9
0
0
0
0
0
21
6
23
0
0
11
2
7
24
447
483
1
10
30
92
1,567
1,5679230101483447247211002362100000917018861,1124,00319136611164630
   > Long-term Assets 
14,489
14,608
13,797
11,290
16,462
20,404
26,176
30,718
21,408
12,925
7,309
0
0
1,471
2,015
181
1,973
1,983
1,978
1,972
1,967
6
2
0
0
0
0
0
0
0
12
534
340
3,536
10,857
29,563
29,56310,8573,536340534120000000261,9671,9721,9781,9831,9731812,0151,471007,30912,92521,40830,71826,17620,40416,46211,29013,79714,60814,489
       Property Plant Equipment 
8,081
7,471
9,217
8,351
12,430
14,930
19,714
19,790
13,585
11,763
7,118
0
0
108
85
2
12
26
21
16
10
6
2
0
0
0
0
0
0
0
12
445
278
179
65
72
7265179278445120000000261016212612285108007,11811,76313,58519,79019,71414,93012,4308,3519,2177,4718,081
       Goodwill 
1,585
1,501
1,419
0
0
0
0
0
0
0
0
0
0
0
0
0
1,961
1,957
1,957
1,957
1,957
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000001,9571,9571,9571,9571,96100000000000001,4191,5011,585
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
89
62
62
0
0
006262890000000000000000000000000000000
       Intangible Assets 
600
680
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,961
1,957
1,957
1,957
1,957
1,957
0
0
0
0
0
0
0
0
0
0
3,295
3,295
10,729
29,492
29,49210,7293,2953,29500000000001,9571,9571,9571,9571,9571,96100000000000000680600
       Long-term Assets Other 
3,477
3,757
2,330
1,615
2,333
3,680
3,957
7,530
7,685
1,147
68
0
0
77
28
179
0
0
0
0
0
-1,957
0
0
0
0
0
0
0
0
-12
0
-278
-3,475
-6,921
29,492
29,492-6,921-3,475-2780-1200000000-1,95700000179287700681,1477,6857,5303,9573,6802,3331,6152,3303,7573,477
> Total Liabilities 
11,819
13,623
14,538
14,515
19,684
22,521
29,718
19,133
18,216
14,610
8,065
118
169
458
289
182
223
284
603
1,082
1,139
1,855
2,274
2,352
2,509
310
92
516
471
1,426
4,585
1,674
1,150
5,886
1,885
3,732
3,7321,8855,8861,1501,6744,5851,426471516923102,5092,3522,2741,8551,1391,0826032842231822894581691188,06514,61018,21619,13329,71822,52119,68414,51514,53813,62311,819
   > Total Current Liabilities 
9,293
10,832
11,697
11,431
15,821
18,245
25,066
12,778
17,256
13,963
7,508
118
169
443
275
182
222
284
603
1,082
1,139
971
886
2,352
2,509
310
92
516
471
1,426
4,585
1,378
1,038
5,886
1,885
3,732
3,7321,8855,8861,0381,3784,5851,426471516923102,5092,3528869711,1391,0826032842221822754431691187,50813,96317,25612,77825,06618,24515,82111,43111,69710,8329,293
       Short-term Debt 
3,684
3,906
4,636
5,187
5,208
5,639
3,385
1,109
477
179
815
0
0
0
0
0
1
0
0
0
0
0
311
477
428
0
0
0
0
0
124
124
147
122
0
0
0012214712412400000428477311000001000008151794771,1093,3855,6395,2085,1874,6363,9063,684
       Accounts payable 
1,863
1,655
2,426
2,783
4,847
5,802
12,081
5,654
7,196
7,992
5,109
118
169
100
62
182
194
94
275
148
332
137
134
259
205
280
0
456
454
911
4,117
1,177
652
4,682
1,391
2,728
2,7281,3914,6826521,1774,117911454456028020525913413733214827594194182621001691185,1097,9927,1965,65412,0815,8024,8472,7832,4261,6551,863
       Other Current Liabilities 
3,746
5,271
4,635
3,461
5,766
6,472
8,862
5,543
8,072
5,139
1,437
0
169
343
213
182
27
190
328
933
807
835
442
1,615
331
30
91
60
17
515
468
77
239
1,081
494
1,004
1,0044941,08123977468515176091303311,6154428358079333281902718221334316901,4375,1398,0725,5438,8626,4725,7663,4614,6355,2713,746
   > Long-term Liabilities 
2,526
2,791
2,841
3,084
3,863
4,276
4,652
6,355
960
647
557
0
0
15
15
0
1
0
0
0
0
884
1,388
0
0
0
0
0
0
0
296
296
112
5,790
0
0
005,79011229629600000001,3888840000101515005576479606,3554,6524,2763,8633,0842,8412,7912,526
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
296
112
0
0
0
0001122960000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
15
15
0
0
0
0
0
0
884
1,388
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000001,38888400000015150000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,874
0
03,8740000000000000000000000000000000000
> Total Stockholder Equity
11,979
11,664
12,560
11,406
12,879
19,582
37,093
37,908
32,046
15,837
8,084
5,150
5,695
4,047
2,649
2,245
3,430
2,224
2,897
1,286
878
-1,797
-2,231
-2,334
-2,501
2,244
1,229
3,181
5,437
16,285
615
23,637
20,800
8,152
22,951
108,733
108,73322,9518,15220,80023,63761516,2855,4373,1811,2292,244-2,501-2,334-2,231-1,7978781,2862,8972,2243,4302,2452,6494,0475,6955,1508,08415,83732,04637,90837,09319,58212,87911,40612,56011,66411,979
   Common Stock
8,266
8,266
8,266
8,841
9,013
12,513
19,623
19,625
22,512
22,512
35,926
36,601
37,499
37,261
37,261
37,816
68,766
8,249
11,433
13,447
15,970
17,017
18,228
19,704
21,372
25,658
25,658
4,717
11,632
33,299
33,890
71,414
71,476
71,476
93,490
188,320
188,32093,49071,47671,47671,41433,89033,29911,6324,71725,65825,65821,37219,70418,22817,01715,97013,44711,4338,24968,76637,81637,26137,26137,49936,60135,92622,51222,51219,62519,62312,5139,0138,8418,2668,2668,266
   Retained Earnings 
625
326
1,226
-540
1,153
3,621
7,303
8,799
-3,875
-20,945
-28,153
-31,325
-31,804
-33,214
-34,613
-35,571
-65,336
-6,376
-9,777
-12,602
-15,646
-17,634
-21,111
-22,679
-24,528
-25,195
-26,209
-1,708
-6,481
-17,493
-34,532
-51,263
-54,597
-67,768
-76,922
-90,792
-90,792-76,922-67,768-54,597-51,263-34,532-17,493-6,481-1,708-26,209-25,195-24,528-22,679-21,111-17,634-15,646-12,602-9,777-6,376-65,336-35,571-34,613-33,214-31,804-31,325-28,153-20,945-3,8758,7997,3033,6211,153-5401,226326625
   Accumulated Other Comprehensive Income 
3,088
3,072
3,068
3,105
2,713
3,448
10,167
9,484
13,409
14,270
311
-126
0
-37
-62
-3
-2
352
441
441
553
600
651
641
655
1,780
1,780
173
286
479
1,258
3,486
3,922
4,444
6,383
11,204
11,2046,3834,4443,9223,4861,2584792861731,7801,780655641651600553441441352-2-3-62-370-12631114,27013,4099,48410,1673,4482,7133,1053,0683,0723,088
   Capital Surplus 000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000



5.4. Balance Sheets

Currency in AUD. All numbers in thousands.